Physician profile
John Stoneham
NPI 1982650644
$1,787.98
in general payments reported to CMS, 2019-2025
32 companies · $492 in 2025
The $492 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $578 · 2020: $93.76 · 2021: $268 · 2022: $40.85 · 2023: $69.33 · 2024: $246 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $384.27 | 2019-2025 | Lupron Depot |
| Sumitomo Pharma America, INC. | $207.86 | 2024-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $197.66 | 2019-2025 | Xtandi |
| Medtronic, INC. | $97.09 | 2024 | Interstim |
| Allergan, INC. | $94.64 | 2019 | |
| Pfizer INC. | $90.20 | 2019-2025 | |
| Coloplast Corp | $70.80 | 2019-2024 | |
| Dendreon Pharmaceuticals LLC | $53.08 | 2019-2020 | |
| Bioprotect Medical, INC. | $50.77 | 2025 | Bioprotect Balloon Implant System |
| Immunitybio, INC. | $48.92 | 2025 | |
| 180 Medical, INC. | $42.62 | 2019-2021 | |
| Janssen Biotech, INC. | $41.55 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.05 | 2019-2020 | |
| Medtronic USA, INC. | $33.84 | 2019 | |
| Tolmar, INC. | $33.81 | 2025 | Eligard |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $31.07 | 2019-2024 | Ams 700 |
| Ferring Pharmaceuticals INC. | $28.76 | 2019-2025 | Adstiladrin |
| Calyxo, INC. | $26.77 | 2025 | Cvac Aspiration System |
| Olympus America INC. | $22.64 | 2025 | Soltive |
| Photocure INC | $19.80 | 2025 | Cysview |
| Axonics, INC. | $19.80 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.08 | 2025 | |
| Antares Pharma, INC. | $15.99 | 2024 | Xyosted |
| Urovant Sciences INC | $14.99 | 2021 | |
| Urogen Pharma, INC. | $14.48 | 2025 | |
| Myriad Genetic Laboratories, INC. | $14.22 | 2021 | |
| Myovant Sciences INC. | $13.99 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $12.78 | 2019 | |
| Aytu Biopharma, INC. | $12.49 | 2019 | |
| Blue Earth Diagnostics | $12.28 | 2019 | |
| Metuchen Pharmaceuticals | $12.15 | 2021 | |
| Dentsply Ih INC. | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Stoneham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.